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     A radioimmunoassay (RIA) of estradiol was performed with the use of antiserum 
produced by estradiol-6-oxim-BSA. The precision of the assay was such as to result in 
a within-assay variance of 10.1% and a between-assay variance of 31.8%. 
     The concentrations of estradiol thus determined in the serum of women with normal 
menstrual cycles were 69.0±40.6 pg/ml inthe menstrual phase, 127.8±70.3 pg/ml in the 
follicular phase, 281.9±113.5 pg/ml in the ovulatory phase, and 165.4±79.5 pg/ml in the 
luteal phase. 
     The blood estradiol level durinh pregnancy ranged from 0.28 to 13.17 ng/ml in the 
first trimester, 2.6 to 48.1 ng/ml in the second trimester, and 13.5 to 130.0 nh/ml in the 
third trimester.
                   INTRODUCTION 
     There have been a number of reports"~" on the radioimmunassay of serum estradiol 
since 1969 when this assay method was first revealed by ABRAHAM'). The study reported 
on here involved the RIA of estradiol using antiserum produced by estradiol-6-oxim BSA.
*　 　森 　 淳 躬,石 丸 忠 之
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                     METHODS 
1) Reagents and Appliances 
     Radioactive estradiol : Estradiol-17i9-6.7-3H (New England Nuclear Corporation, 
Boston, U. S. A., specific activity 46.6 Ci/mM, E2-3H) was stored at 4°C after puri-
fication in a Sephadex LH-20 microcolumn and dilution to a concentration of 1 x 105 dpm/ 
ml with methanol. 
      Non-radioactive estradiol : A pure substance (Teikokuzoki Co., Tokyo) was used, 
and a series of dilutions ranging in concentration from 5 ng/ml to 125 pg/ml were prepared 
and stored at 4°C. Bovine plasma r-globulin (ICN Pharmaceuticals Inc. , Ohio, U.S.A.) 
and bovine serum albumin (BSA) were used as serums to be added to the buffer. 
     Dextran charcoal solution : One gram of purified charcoal and 0.1 g of Dextran T-
70 (Pharmacia Fine Chemicals Co., Sweden) were dissolved in 100 ml of 0.05M borate 
buffer and then stored at 4°C. 
     Scintillation solution : A dioxane scintillation solution was prepared by dissolving 
0.5 g of 1.4 - Bis (5-Phenyl-oxazolyl) - benzene ' (POPOP) , 20 g of 2. 5-D phenyloxazole 
(PPO), and 200 g of naphthalene in 2,000 ml of dioxane. 
     Sephadex LH-20 column chromatography : The chromatographic procedure was in 
accordance with the method of WU et all). Sephadex LH-20 was suspended in a 85 :15 
mixture of benzene and methanol and packed to a height of 60 mm in a 7 x 100 mm 
microcolumn. 
    Liquid scintillation counter : The ALOKA LSC-651 (Tokyo) liquid scintillation 
counter was utilized. Each sample was subjected to a scintillation count for five minutes. 
Counting vials were of the low background type.
Table 1. Cross reaction with various steroidsof estradiol-6-oxim 
        BSA antibody (From Yoshida et all).)
     Steroids Cross rreaction Steroids Cross reaction                    (/
o) (%) 
estradiol-17(3 100 androst-4-ene, 3-17-dione 0.44 
16 oxoestradiol 0.80 dehpdroepiandrosterone X0.08 
estradion-17(3 0.80 pregnenolone <0.08 
estrone 3.20 progesterone <0.08 
2-methoxy-estrone <0.08 17 3-hydroxyprogesterone <0.08 
estrone-3-sulfate 8.00 cortisol <0.08 
estriol 1.77 corticosterone <0. 08 
16-epiestriol 5.33 cortisone X0.08 
estriol-16-glucuronide <0.08 cholesterol <0.08 
testosterone 0.29
     Estradiol antiserum : Estradiol was combined with BSA by introducing at OXO 
group at C-6, a position that has no bearing on the biologic activity of the substance, 
while the active OH groups at C-3 and C-17 were kept intact. The resulting estradiol-
6-oxim-BSA was injected into rabbits to obtain an estradiol antiserum. The specificity of 
the antiserum is shown in Table 1. 
2) Plasma Extraction, Separation and Purification 
     Blood samples were immediately centrifuged at 2,500-3,000 rpm for 10 minutes and 
then the serum was stored at -25'C. Al x 103 dpm volume of 3H-estradiol was added to 
the serum to produce an internal standard for recovery estimations. The substance under 
investigation was then extracted with 4ml of ethyl ether, following which the extract was
Fig. 1 Standard curves with different antserum dilutions
dried by spraying of N2 gas in a thermostat at 37-40°C. The dried residue was dissolved 
in 0. 2ml of an 85 : 15 mixture of benzene and methanol. 
3) Antiserum Titer 
     Binding rate of 1 x 104 dpm of 3H-estradiol to the antiserum was 86.3-L3.8% at an 
antiserum dilution of 2 x 104, 83.1±1.0% at an antiserum dilution of 4 x 104, and 71.64-
1.8% at an antiserum dilution of 8 x 104 (Fig. 1). 
     The binding rate of standard estradiol in a range of 0-1,000 pg varied in an almost 
linear fashion when the antiserum dilution rate was 4 x 104. Within this standard range, 
the binding values displayed a standard deviation of ±0.2-±1.8, with a coefficient of 
0.5-6.0%. These findings led us to utilize an antiserum dilution of 4 x 104 in the present 
study. 
4) Incubation Time and Temprature 
     A study, using a 4 x 104-fold dilution of antiserum, was made as to the relationship 
between incubation time and incubation temperature. It was found that the incubation 
time required for 3H-estradiol to be bound to antiserum at a rate exceeding 80% was 90-
120 minutes at 4°C and 20-30 minutes at room temperature (15-28'C). 
5) Chromatography 
     A chromatographic study was made with a Sephadex LH-20 microcolum in accordance 
with the method of Wu5) et al. The elution patterns thus obtained are shown in Fig. 2.
Fig. 2 Fractionation of estrogen in Sephadex LH-20 column chromatography
6) Precision 
     A coefficient of variation of 2.5-17.0% was obtained with estradiol added, in amounts 
of 0-500 pg, to 1ml of distilled water. The precision was such as to give (4) within-assay 
variance of 10.1% (n=10) and a between-assay variance of 31.8% (n::--9). 
7) RIA 
     After considering all of the afore-mentioned results and the conditions involved in 
the present study, we decided on the estradiol radioimmunoassay procedure as outlined 
in Fig. 3. 
     Incidentally, the concentration in lml of serum of estradiol of the unconjugated type 
was calculated from the following formula : 
       Estradiol level (Pg/ml) = R %Pg R e - (M+B)) 
                                X 1                                              Volume of seru m under 
                                            examination (ml)
Serum, 0.1-2.Oml 
          Addition of estradiol-3H (1000 dpm) for correction 
            of recovery rate 
Extraction, with 4ml of ethyl ether (X2 mal) 
Drying with N2 gas spray in thermostat at 37-40°C 
Sephadex LH-20 column chromatography 
           0.5ml for correction of recovery rate 
           1.Oml submitted to assay 
Radioimmunoassay 
          1 x 104dpm of estradiol-3H added 
          Dried by N2 gas spray 
           Incubated for 30 minuttes at room temperature with 
          0.3ml of antiserum (1: 4 x 104 dilution) added. 
Separation of free from bound from 
           0.3m1 of dextran-coated charcoal addedin ice 
           water bath. Allowed to stand for minutes.
           Centrifuged at. 2,600-3,000 rpm for 1.0 minutes. 
Determination 
           Concentrationcalculated from the standard curve. 
           Fig. 3 Sequential steps in estradiol RIA
where E denotes the total amount of eluate in chromatography ; Re, recovery rate (%) ; 
R, the amount of eluate used in RIA ; M, the concentration of 3H-estradiol for correction 
of the recovery rate (Pg), % Pg, the concentration of estradiol as obtained from the sta-
ndard curve (Pg) ; and B, the concentration of estradiol for the blank (Pg).
                     RESULTS 
     In women with a normal menstrual cycle, the serum level of estradiol was 69.0 ± 
40.6 Pg/ml (n=57) for the menstrual phsae, 281.9±113.5 Pg/ml (n= 15) for the ovulatory 
phase, and 165.4±79.5 Pg/ml (n=63) for the luteal phase. Determinations of serum 
estradiol levels were made daily throughout each cycle of four women experiencing normal 
menstrual cycles. The results are shewn in Fig. 4. 
     The serum estradiol level during pregnancy ranged from 0.28 to 13.17 ng/ml (n= 
50) for the first trimester (7th-16th weeks), from 2.6 to 48. 1 ng/ml (n = 17) for the second 
trimester (17th-28th weeks), and from 13.5 to 130.0 ng/ml (n=111) for the third trimester 
(29th-43rd weets). The measurements made every week after the 36th week in 18 cases 
of pregnancy are plotted in Fig. 5.
Fig. 4 Variation in estradiol level in 4 women with normal menstrual cycle 
       (The thick line indicates mean values for -,,cases.)
          Hollow circles indicate values at onset of paids. 
Fig. 5 Variation in estradiol level at the 36th and later weeks of pregnancy
                   DISCUSSION 
     Antiserum produced by estradiol-6-oxim BSA is more specific for estradiol and also 
of better quality respect to sensitivity and precision that conventional antiserum prod-
uced by estradiol - 17(3 - succinyl BSA. On the other hand, it must be mentioned that 
estradiol is contained in the lipid extracted from serum, giving rise to a variation in the 
results of RIA, as pointed out by MAKINO47 and HASHIMOTO3). In the present study, 
a microcolumn was used with a view to removing lipid and purifying estradiol. As a 
result, a mean recovery rate of 68.7±10.2% was attained for the entire process of extraction, 
the rate being as high as 94.3±8.0% in as much as the microcolumn alone was concerned. 
The use of a Sephadex LH-20 column as a means of removing impurities in the blood 
involves a somewhat complicated procedure, whereas the microcolumn is capable of dealing 
with a number of specimens in a short period of time. The latter also is economical, 
permitting repeated use. 
     A review of actual measurements disclosed that the serum concentration of estradiol 
in women with a normal menstrual cycle roughly corresponded with the figures reported 
by other investigators (Table 2). Daily determination of blood estradiol level revealed that 
the level was at its lowest during the menstrual phase, then rose gradually during the
follicular phase, and sharply for4 to 5 days before the LH peak until a peak was reached 
during the ovulatory phase. It then showed a rapid decline, followed around 7 to 8 days 
after ovulation by a rise up to a peak for the luteal phase, and then finally declined. 
     The serum level of estradiol at different weeks of pregnancy varied markedly in 
different individuals. There was a prominent individual difference observed in the maximal 
value-ranging from 24.5 to 130 ng/ml-obtained in 18 cases from the 36th week until the 
onset of labor. The estradiol level at onset of pains was lower than that at 1-2 weeks 
before delivery in 14, but higher in 3, of 18 cases. No difference was noted in the one 
remaining case. Blood estradiol level rises sharply around 40 days after fertilizations), and 
the luteoplacental shift occurs around 50-60 days after fertilization) with the subsequent
                    Table 2. Blood estradiol levels in women with normal 
                              menstrual cycles 
    Method of Time of Value obtained (pg/ml) Person in change     determina - d
eterminatino (number of cases) of determination     tion 
                 Follicular phase 29-85 ( 9) 
     DIDD Ovulatory phase 318±98 (13) Baird (1969) 
                Luteal phase 191±49 ( 6) 
                  Follicular phase 65.6±14.3 (15) Korenma n      CPBA Ov ulatory phase 124.5±49.6 (12) (1969
,1970)                   Luteal phase 137.2±35.6 ( 6) 
                  Follicular phase 10^-100 (12)
      CPB Ovulatory phase 140^-770 (12) Dufan (1970)                                     (350±145)
                Luteal phase 190-340 (12) 
      RIA Follicular phase 108±13 Abraham (1969)                  (pooling) 
     RIA Women (pooling) 145±24 ( 6) Mikhail (1970)                 Ovulatory phase 513 42 8
                  3rd day of menstrual 21 .4±2.62 ( 4) 
                  cycle (1971)       RIA 
27th day of menstrual 68 .5±4.70 ( 4) Wu cycle 
                 Follicular phase 87± 34.5 (12) 
     RIA Ovulatory phase 352±128.8 (12) Yamaji (1972) 
                Luteal pphase 110± 89.2 (16) 
                 Follicular phase 102.5±28.2 (10) 
      RIA Ovulatory phase 284.4±99.2 ( 5) Hashimoto(1974) 
                 Luteal phase 150.4±60.2 (17) 
                 Follicular phase 62.8±22.9 
      RIA Intermediate phase 204.9±84.7 Kawagoe (1974) 
                  Luteal phase 119.4±46.7 
                 Menstrual phase 69.0± 40.6 (29) 
                 Follicular phase 127.8± 70.3 (57) 
      RIA Ovulatory phase 281.9±113.5 (15) Miura (1976) 
                 Luteal phase 165.4- 79.5 (63) 
                 Peak of ovulation 384.7±127.7 ( 5)
biosynthesis of estrogens in large quantities in the chorionic villi. It is evident that DHAS 
from the fetal adrenal is the precursor of estrogens, particularly estriol synthesized in the 
placenta. Hence, the urine or blood level of estriol is a reflection of the functional status of 
the fetus or placenta. At the same time, the variation in the level of estriol, whose activity 
is much less potent than that of estrogens, is also of importance in analyzing the physiologi-
cal phenomena that occur during pregnancy. Further investigation is needed in this res-
pect.
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